187 related articles for article (PubMed ID: 16014396)
1. 3,5-diiodo-L-thyronine powerfully reduces adiposity in rats by increasing the burning of fats.
Lanni A; Moreno M; Lombardi A; de Lange P; Silvestri E; Ragni M; Farina P; Baccari GC; Fallahi P; Antonelli A; Goglia F
FASEB J; 2005 Sep; 19(11):1552-4. PubMed ID: 16014396
[TBL] [Abstract][Full Text] [Related]
2. 3,5-diiodo-l-thyronine, by modulating mitochondrial functions, reverses hepatic fat accumulation in rats fed a high-fat diet.
Mollica MP; Lionetti L; Moreno M; Lombardi A; De Lange P; Antonelli A; Lanni A; Cavaliere G; Barletta A; Goglia F
J Hepatol; 2009 Aug; 51(2):363-70. PubMed ID: 19464748
[TBL] [Abstract][Full Text] [Related]
3. Pathways affected by 3,5-diiodo-l-thyronine in liver of high fat-fed rats: evidence from two-dimensional electrophoresis, blue-native PAGE, and mass spectrometry.
Silvestri E; Cioffi F; Glinni D; Ceccarelli M; Lombardi A; de Lange P; Chambery A; Severino V; Lanni A; Goglia F; Moreno M
Mol Biosyst; 2010 Nov; 6(11):2256-71. PubMed ID: 20844788
[TBL] [Abstract][Full Text] [Related]
4. TRC150094, a novel functional analog of iodothyronines, reduces adiposity by increasing energy expenditure and fatty acid oxidation in rats receiving a high-fat diet.
Cioffi F; Zambad SP; Chhipa L; Senese R; Busiello RA; Tuli D; Munshi S; Moreno M; Lombardi A; Gupta RC; Chauthaiwale V; Dutt C; de Lange P; Silvestri E; Lanni A; Goglia F
FASEB J; 2010 Sep; 24(9):3451-61. PubMed ID: 20453112
[TBL] [Abstract][Full Text] [Related]
5. Acute administration of 3,5-diiodo-L-thyronine to hypothyroid rats stimulates bioenergetic parameters in liver mitochondria.
Cavallo A; Taurino F; Damiano F; Siculella L; Sardanelli AM; Gnoni A
J Bioenerg Biomembr; 2016 Oct; 48(5):521-529. PubMed ID: 27854029
[TBL] [Abstract][Full Text] [Related]
6. Effects of 3,5-diiodo-L-thyronine administration on the liver of high fat diet-fed rats.
Grasselli E; Canesi L; Voci A; De Matteis R; Demori I; Fugassa E; Vergani L
Exp Biol Med (Maywood); 2008 May; 233(5):549-57. PubMed ID: 18375830
[TBL] [Abstract][Full Text] [Related]
7. 3,5-diiodo-L-thyronine increases resting metabolic rate and reduces body weight without undesirable side effects.
Antonelli A; Fallahi P; Ferrari SM; Di Domenicantonio A; Moreno M; Lanni A; Goglia F
J Biol Regul Homeost Agents; 2011; 25(4):655-60. PubMed ID: 22217997
[TBL] [Abstract][Full Text] [Related]
8. 3,5-Diiodo-L-Thyronine Exerts Metabolically Favorable Effects on Visceral Adipose Tissue of Rats Receiving a High-Fat Diet.
Silvestri E; Senese R; Cioffi F; De Matteis R; Lattanzi D; Lombardi A; Giacco A; Salzano AM; Scaloni A; Ceccarelli M; Moreno M; Goglia F; Lanni A; de Lange P
Nutrients; 2019 Jan; 11(2):. PubMed ID: 30691227
[TBL] [Abstract][Full Text] [Related]
9. 3,5-Diiodo-L-thyronine rapidly enhances mitochondrial fatty acid oxidation rate and thermogenesis in rat skeletal muscle: AMP-activated protein kinase involvement.
Lombardi A; de Lange P; Silvestri E; Busiello RA; Lanni A; Goglia F; Moreno M
Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E497-502. PubMed ID: 19116374
[TBL] [Abstract][Full Text] [Related]
10. Phenotype-based treatment of dietary obesity: differential effects of fenofibrate in obesity-prone and obesity-resistant rats.
Ji H; Outterbridge LV; Friedman MI
Metabolism; 2005 Apr; 54(4):421-9. PubMed ID: 15798946
[TBL] [Abstract][Full Text] [Related]
11. 3,5-Diiodo-L-thyronine prevents high-fat-diet-induced insulin resistance in rat skeletal muscle through metabolic and structural adaptations.
Moreno M; Silvestri E; De Matteis R; de Lange P; Lombardi A; Glinni D; Senese R; Cioffi F; Salzano AM; Scaloni A; Lanni A; Goglia F
FASEB J; 2011 Oct; 25(10):3312-24. PubMed ID: 21670063
[TBL] [Abstract][Full Text] [Related]
12. 3,5 Diiodo-L-Thyronine (T2) Does Not Prevent Hepatic Steatosis or Insulin Resistance in Fat-Fed Sprague Dawley Rats.
Vatner DF; Snikeris J; Popov V; Perry RJ; Rahimi Y; Samuel VT
PLoS One; 2015; 10(10):e0140837. PubMed ID: 26485433
[TBL] [Abstract][Full Text] [Related]
13. Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates.
Jobgen WS; Fried SK; Fu WJ; Meininger CJ; Wu G
J Nutr Biochem; 2006 Sep; 17(9):571-88. PubMed ID: 16524713
[TBL] [Abstract][Full Text] [Related]
14. Investigation of potential mechanisms regulating protein expression of hepatic pyruvate dehydrogenase kinase isoforms 2 and 4 by fatty acids and thyroid hormone.
Holness MJ; Bulmer K; Smith ND; Sugden MC
Biochem J; 2003 Feb; 369(Pt 3):687-95. PubMed ID: 12435272
[TBL] [Abstract][Full Text] [Related]
15. Nonthyrotoxic prevention of diet-induced insulin resistance by 3,5-diiodo-L-thyronine in rats.
de Lange P; Cioffi F; Senese R; Moreno M; Lombardi A; Silvestri E; De Matteis R; Lionetti L; Mollica MP; Goglia F; Lanni A
Diabetes; 2011 Nov; 60(11):2730-9. PubMed ID: 21926273
[TBL] [Abstract][Full Text] [Related]
16. Acute administration of 3,5-diiodo-L-thyronine to hypothyroid rats affects bioenergetic parameters in rat skeletal muscle mitochondria.
Lombardi A; Lanni A; de Lange P; Silvestri E; Grasso P; Senese R; Goglia F; Moreno M
FEBS Lett; 2007 Dec; 581(30):5911-6. PubMed ID: 18054334
[TBL] [Abstract][Full Text] [Related]
17. Efficiency of intermittent exercise on adiposity and fatty liver in rats fed with high-fat diet.
Sene-Fiorese M; Duarte FO; Scarmagnani FR; Cheik NC; Manzoni MS; Nonaka KO; Rossi EA; de Oliveira Duarte AC; Dâmaso AR
Obesity (Silver Spring); 2008 Oct; 16(10):2217-22. PubMed ID: 18719640
[TBL] [Abstract][Full Text] [Related]
18. 3,5 Diiodo-l-Thyronine (T₂) Promotes the Browning of White Adipose Tissue in High-Fat Diet-Induced Overweight Male Rats Housed at Thermoneutrality.
Senese R; Cioffi F; De Matteis R; Petito G; de Lange P; Silvestri E; Lombardi A; Moreno M; Goglia F; Lanni A
Cells; 2019 Mar; 8(3):. PubMed ID: 30889829
[TBL] [Abstract][Full Text] [Related]
19. 3,5-Diiodo-L-thyronine administration to hypothyroid rats rapidly enhances fatty acid oxidation rate and bioenergetic parameters in liver cells.
Cavallo A; Priore P; Gnoni GV; Papa S; Zanotti F; Gnoni A
PLoS One; 2013; 8(1):e52328. PubMed ID: 23308110
[TBL] [Abstract][Full Text] [Related]
20. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.
Stefanovic-Racic M; Perdomo G; Mantell BS; Sipula IJ; Brown NF; O'Doherty RM
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E969-77. PubMed ID: 18349115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
